MedTrace Logo

Effects of Different Caffeine Forms on Aerobic and Anaerobic Exercise Performance

NCT07497685 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2026-03-27

No results posted yet for this study

Summary

This study investigated the effects of different caffeine delivery forms on aerobic and anaerobic exercise performance in healthy adults. Participants completed experimental trials involving caffeine capsule ingestion, caffeine gum chewing, and caffeine mouth rinse conditions. Aerobic performance was assessed using maximal oxygen uptake (VO2max), and anaerobic performance was evaluated using the Wingate anaerobic test. The study used a randomized crossover design where each participant completed all experimental conditions.

Conditions

  • Exercise Performance
  • Physical Performance

Interventions

OTHER

Comparative Acute Effects of Caffeine Delivery Forms (Capsule, Chewing Gum, Mouth Rinse) on Aerobic Capacity and Wingate Anaerobic Performance Outcomes in Recreational Male Athletes: A Randomized Coun

This study evaluates the acute effects of three distinct caffeine delivery methods compared to a placebo, using a standardized total dose of 300 mg of caffeine across all active interventions. The study is a randomized, single-blind, counterbalanced crossover trial involving 14 recreational male athletes. The interventions are distinguished by their specific absorption kinetics and ecologically valid administration timings

Sponsors & Collaborators

  • University of Gaziantep

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-10
Primary Completion
2024-11-10
Completion
2025-03-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07497685 on ClinicalTrials.gov